Carlin Jesse Lea, Tosh Dilip K, Xiao Cuiying, Piñol Ramón A, Chen Zhoumou, Salvemini Daniela, Gavrilova Oksana, Jacobson Kenneth A, Reitman Marc L
Diabetes, Endocrinology, and Obesity Branch (J.L.C., C.X., R.A.P., M.L.R.), Molecular Recognition Section, Laboratory of Bioorganic Chemistry (D.K.T., K.A.J.), and Mouse Metabolism Core (O.G.), National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland; and Department of Pharmacological and Physiological Science, Saint Louis University School of Medicine, St. Louis, Missouri (Z.C., D.S.).
Diabetes, Endocrinology, and Obesity Branch (J.L.C., C.X., R.A.P., M.L.R.), Molecular Recognition Section, Laboratory of Bioorganic Chemistry (D.K.T., K.A.J.), and Mouse Metabolism Core (O.G.), National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland; and Department of Pharmacological and Physiological Science, Saint Louis University School of Medicine, St. Louis, Missouri (Z.C., D.S.)
J Pharmacol Exp Ther. 2016 Feb;356(2):474-82. doi: 10.1124/jpet.115.229872. Epub 2015 Nov 25.
Adenosine can induce hypothermia, as previously demonstrated for adenosine A1 receptor (A1AR) agonists. Here we use the potent, specific A3AR agonists MRS5698, MRS5841, and MRS5980 to show that adenosine also induces hypothermia via the A3AR. The hypothermic effect of A3AR agonists is independent of A1AR activation, as the effect was fully intact in mice lacking A1AR but abolished in mice lacking A3AR. A3AR agonist-induced hypothermia was attenuated by mast cell granule depletion, demonstrating that the A3AR hypothermia is mediated, at least in part, via mast cells. Central agonist dosing had no clear hypothermic effect, whereas peripheral dosing of a non-brain-penetrant agonist caused hypothermia, suggesting that peripheral A3AR-expressing cells drive the hypothermia. Mast cells release histamine, and blocking central histamine H1 (but not H2 or H4) receptors prevented the hypothermia. The hypothermia was preceded by hypometabolism and mice with hypothermia preferred a cooler environmental temperature, demonstrating that the hypothermic state is a coordinated physiologic response with a reduced body temperature set point. Importantly, hypothermia is not required for the analgesic effects of A3AR agonists, which occur with lower agonist doses. These results support a mechanistic model for hypothermia in which A3AR agonists act on peripheral mast cells, causing histamine release, which stimulates central histamine H1 receptors to induce hypothermia. This mechanism suggests that A3AR agonists will probably not be useful for clinical induction of hypothermia.
腺苷可诱发体温过低,正如先前对腺苷A1受体(A1AR)激动剂所证明的那样。在此,我们使用强效、特异性的A3AR激动剂MRS5698、MRS5841和MRS5980来表明腺苷也通过A3AR诱发体温过低。A3AR激动剂的体温过低效应独立于A1AR激活,因为在缺乏A1AR的小鼠中该效应完全存在,但在缺乏A3AR的小鼠中则消失。肥大细胞颗粒耗竭减弱了A3AR激动剂诱导的体温过低,表明A3AR介导的体温过低至少部分是通过肥大细胞实现的。中枢给予激动剂没有明显的体温过低效应,而外周给予非脑渗透性激动剂则导致体温过低,这表明外周表达A3AR的细胞驱动了体温过低。肥大细胞释放组胺,阻断中枢组胺H1(而非H2或H4)受体可预防体温过低。体温过低之前存在代谢减退,体温过低的小鼠更喜欢较低的环境温度,这表明体温过低状态是一种体温设定点降低的协调生理反应。重要的是,A3AR激动剂的镇痛作用不需要体温过低,较低剂量的激动剂即可产生镇痛作用。这些结果支持了一种体温过低的机制模型,其中A3AR激动剂作用于外周肥大细胞,导致组胺释放,组胺刺激中枢组胺H1受体诱导体温过低。这种机制表明A3AR激动剂可能对临床诱导体温过低无用。